Upcyte-P Tablet

Introduction

Upcyte-P is a prescription medication that contains a combination of active ingredients, including Benfotiamine, Folic Acid, Methylcobalamin, Pregabalin, and Vitamin B6. It is commonly used to address certain health conditions and provide essential nutrients to the body.

Uses

Upcyte-P is primarily prescribed for the treatment of neuropathic pain, which is caused by nerve damage. It may also be used to support nerve health and function, promote healthy blood cells, and provide nutritional support.

Dosage and Administration

The dosage and administration of Upcyte-P should be determined by a healthcare professional based on individual patient factors and the specific condition being treated. Follow the prescribed dosage instructions carefully. The tablets are usually taken orally with water, and can be taken with or without food. Swallow the tablet whole and not crush or chew it unless specifically instructed to do so.

Mechanism of Action

Upcyte-P contains a combination of active ingredients that work together to provide therapeutic effects. Benfotiamine, Folic Acid, Methylcobalamin, Pregabalin, and Vitamin B6 each have specific mechanisms of action that contribute to the overall effectiveness of the medication. Benfotiamine and Methylcobalamin are forms of vitamin B that are involved in various metabolic processes and nerve function. Folic Acid is essential for the production of healthy blood cells, while Pregabalin helps to reduce neuropathic pain. Vitamin B6 is important for the proper functioning of the nervous system.

Side Effects

Common side effects may include dizziness, drowsiness, nausea, and headache. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult a healthcare professional.

In rare cases, Upcyte-P may cause more serious side effects. These can include allergic reactions, difficulty breathing, swelling of the face, lips, tongue, or throat, and severe skin reactions. If any of these serious side effects occur, immediate medical attention should be sought.

Drug Interactions

Upcyte-P may interact with other medications, including prescription drugs, over-the-counter medicines, and herbal supplements. Inform your healthcare provider about all medications you are currently taking to avoid potential drug interactions. Some medications that may interact with Upcyte-P include certain antacids, anticonvulsants, and medications that affect blood clotting. Your healthcare provider can provide guidance on any potential drug interactions and adjust your treatment plan accordingly.

Precautions

Before taking Upcyte-P, inform your healthcare provider about any known allergies or sensitivities to any of the active ingredients in the medication. Additionally, disclose any other medical conditions or medications you are currently taking. Upcyte-P may not be suitable for individuals with certain medical conditions or those taking specific medications, so consult with a healthcare professional before starting treatment.

Storage

Upcyte-P should be stored in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use any tablets that are past their expiration date or appear to be damaged or tampered with.

Patient Tips

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Folic acid: vitamin that helps the body make healthy red blood cells (NHS UK) [Accessed 0 Jun. 2024] (online) Available at:
• Cernevit (Health Professionals SmPC) Available at:
• Benfotiamine (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• folic acid (RX/OTC) [Accessed 26 Jun. 2024] (online) Available at:
• Thiamin (National Institutes of Health, Office of Dietary Supplements) [Accessed 15 Jun. 2024] (online) Available at:
• Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P. Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial. J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896. [Accessed 10 Jun. 2024] Available at: